The Trump administration is set to bring the first group of white South African refugees to the US, marking a controversial shift in immigration policy that prioritizes this group over others in need.
Google Messages is rolling out a new feature that allows users to delete chat messages for everyone in group conversations. This update aims to enhance user control over messages, but some limitations exist. Details inside!
As tensions rise between India and Pakistan, the Pakistani military claims to have shot down 25 Indian military drones. With both sides on high alert and calls for de-escalation from U.S. officials, the situation remains volatile.
Microsoft has quietly discontinued the 256GB versions of its older Surface devices, leading to effective price increases. The new pricing strategy positions the latest Surface models as better deals, but at what cost to consumers?
As Russia celebrates Victory Day, the event has transformed into a propaganda spectacle under Putin, intertwining historical triumph with today's geopolitical strife. Explore how the Kremlin is reshaping narratives amid rising expectations for peace talks with the U.S.
New research reveals that HIV drugs known as NRTIs can reduce the risk of developing Alzheimer’s disease by 6% to 13% annually. Scientists urge for clinical trials to explore this promising link.
Pope Leo XIV, known for his critical tweets on immigration and politics, continues to engage with hot-button issues post-election. His brother reveals the significance of these topics for the new pontiff.
In a surprising twist, Donald Trump announces his first trade deal with the UK, a country he has a trade surplus with. Celebrated as a significant achievement, the details reveal a more complex reality as both countries seek economic gains.
A resident in Ontario County, NY, has been confirmed to have contracted measles after exposure outside the U.S. Luckily, the case highlights the importance of vaccinations and swift health responses.
Moderna's combined Covid and flu vaccine has outperformed traditional shots in a recent phase 3 trial, generating higher antibody levels and showing promise for dual protection against both viruses.
